EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Epigenetic Inhibitors Differentially Impact TGF-β1 Signaling Cascades in COPD Airway Smooth Muscle Cells

Karosham Diren Reddy iD, Dikaia Xenaki, Ian M Adcock iD, Brian G G Oliver iD, Razia Zakarya

Cells · 2024

DOI: 10.3390/cells14010031 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2024. Verfasst von Karosham Diren Reddy und 4 weiteren Autor:innen. Beteiligte Einrichtung: Respiratory Cellular and Molecular Biology Group, Woolcock Institute of Medical Research, Macquarie University, Macquarie Park, Sydney, NSW 2113, Aus…. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Transforming Growth Factor beta1, DNA Methylation, Myocytes, Smooth Muscle. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Research Council, Australia (NHMRC), National Health and Medical Research Council, Australia (NHMRC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic obstructive pulmonary disease (COPD) is characterized by progressive and incurable airflow obstruction and chronic inflammation. Both TGF-β1 and CXCL8 have been well described as fundamental to COPD progression. DNA methylation and histone acetylation, which are well-understood epigenetic mechanisms regulating gene expression, are associated with COPD progression. However, a deeper understanding of the complex mechanisms associated with DNA methylation, histone post-translational changes and RNA methylation in the context of regulatory pathways remains to be elucidated. We here report on how DNA methylation and histone acetylation inhibition differentially affect CXCL8 signaling in primary human non-COPD and COPD airway cells.

Methods

Airway smooth muscle (ASM) cells, a pivotal cell type in COPD, were isolated from the small airways of heavy smokers with and without COPD. Histone acetylation and DNA methylation were inhibited before the TGF-β1 stimulation of cells. Subsequently, CXCL8 production and the abundance and activation of pertinent transcription regulatory proteins (NF-κB, p38 MAPK and JNK) were analyzed.

Results

TGF-β1-stimulated CXCL8 release from ASM cells from ‘healthy’ smoker subjects was significantly modulated by DNA methylation (56.32 pg/mL and 56.60 pg/mL) and acetylation inhibitors (27.50 pg/mL and 48.85 pg/mL) at 24 and 48 h, respectively. However, modulation via the inhibition of DNA methylation (34.06 pg/mL and 43.18 pg/mL) and acetylation (23.14 pg/mL and 27.18 pg/mL) was observed to a lesser extent in COPD ASM cells. These changes were associated with differences in the TGF-β1 activation of NF-κB and MAPK pathways at 10 and 20 min.

Conclusions

Our findings offer insight into differential epigenetics in controlling COPD ASM cells and provide a foundation warranting future studies on epigenetic differences associated with COPD diagnosis. This would provide a scope for developing therapeutic interventions targeting signaling and epigenetic pathways to improve patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveTransforming Growth Factor beta1DNA MethylationMyocytes, Smooth MuscleEpigenesis, GeneticSignal TransductionHumansMaleInterleukin-8Middle AgedFemaleAcetylationNF-kappa BHistones

Stichwörter der Autor:innen

COPDCXCL8DNA methylationTGF-betaairway smooth muscleepigeneticshistone acetylationinflammationtherapeutics

Substanzen

Transforming Growth Factor beta1Interleukin-8NF-kappa BHistones

Autor:innen und Institutionen

  • Respiratory Cellular and Molecular Biology Group, Woolcock Institute of Medical Research, Macquarie University, Macquarie Park, Sydney, NSW 2113, Australia.
  • School of Life Science, University of Technology Sydney, Ultimo, NSW 2007, Australia.
  • Airways Disease, Respiratory Cell & Molecular Biology, Airways Disease Section, National Heart and Lung Institute, Faculty of Medicine, Imperial College London, London SW7 2BX, UK.
  • Epigenetics of Chronic Disease Group, Woolcock Institute of Medical Research, Macquarie University, Macquarie Park, Sydney, NSW 2113, Australia.

ORCID-Profile: Karosham Diren Reddy, Ian M Adcock, Brian G G Oliver

Förderung

  • National Health and Research Council, Australia (NHMRC)
  • National Health and Medical Research Council, Australia (NHMRC)

Zitieren

APA

Reddy, K. D., Xenaki, D., Adcock, I. M., Oliver, B. G. G., & Zakarya, R. (2024). Epigenetic Inhibitors Differentially Impact TGF-β1 Signaling Cascades in COPD Airway Smooth Muscle Cells. Cells. https://doi.org/10.3390/cells14010031

Vancouver

Reddy KD, Xenaki D, Adcock IM, Oliver BGG, Zakarya R. Epigenetic Inhibitors Differentially Impact TGF-β1 Signaling Cascades in COPD Airway Smooth Muscle Cells. Cells. 2024. doi:10.3390/cells14010031

BibTeX
@article{Reddy2024,
  author = {Reddy, Karosham Diren and Xenaki, Dikaia and Adcock, Ian M and Oliver, Brian G G and Zakarya, Razia},
  title = {Epigenetic Inhibitors Differentially Impact TGF-β1 Signaling Cascades in COPD Airway Smooth Muscle Cells},
  journal = {Cells},
  year = {2024},
  doi = {10.3390/cells14010031}
}
Kostenlos starten →